When was Insellar founded?

Insellar was founded in 2025 and raised its 1st funding round 1 year after it was founded.

Where is Insellar located?

Insellar is headquartered in Germany.

How many employees does Insellar have?

As of Sep 30, 2026, the latest employee count at Insellar is 3.

Is Insellar a funded company?

Insellar is a funded company, having raised a total of $***** in its 1st and only funding round, a Seed round on Apr 13, 2026.

When was the latest funding round of Insellar?

Insellar's latest funding was a $***** Seed round on Apr 13, 2026, with participation from 1 investor. Its primary sector is Neurology. In Germany, the Neurology sector has seen $55.4M in funding in 2026 to date.

Where does Insellar rank among its competitors?

Insellar ranks 30th amongst 49 active competitors, of which 10 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Sonomind, which secured $23.5M in May, 2026.

Who are the top competitors of Insellar?

Insellar's top competitors include Motif neurotech, NeuroSigma and Spark Biomedical. Among them, Sonomind secured the most recent funding round in May, 2026.

Insellar - 2026 Company Profile, Funding & Competitors

Insellar is a seed company based in Germany, founded in 2025. It operates as a Developer of minimally invasive brain interfaces for mental health treatment. Insellar has raised $469K in funding. The company has 49 active competitors, including 10 funded and 4 that have exited. Its top competitors include companies like Motif neurotech, NeuroSigma and Spark Biomedical.

Company Details

Developer of minimally invasive brain interfaces for mental health treatment. These devices utilize physiological mechanisms to address major depressive disorder. The technology integrates with biological systems to modulate neural activity for therapeutic purposes.

Website: insellar.com
Email ID: *****@insellar.com

Key Metrics

Founded Year

2025

Location

Germany

Stage

Seed

Total Funding

$469K in 1 round

Latest Funding Round

Seed, Apr 13, 2026, $*****

Investors

IBB Ventures

Ranked

30^th among 49 active competitors

Employee Count

3 as on Sep 30, 2026

Similar Companies

Motif neurotech & 61 more

View Insellar's full profile

Insellar has raised a total funding of $469K over 1 round. Its latest funding round was a Seed round on Apr 13, 2026 for $*****. 1 investor participated in its latest round. Insellar has 1 institutional investor.

Here is the list of recent funding rounds of Insellar:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Apr 13, 2026	3893872	Seed	9177772	9288598	8902690	1057840

Access funding benchmarks and valuations. Sign up today!

View details of Insellar's funding rounds and investors

Insellar's employee count trend

Insellar has 3 employees as of Sep 26. Here is Insellar's employee count trend over the years:

Uncover Insellar's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Insellar include Motif neurotech, NeuroSigma and Spark Biomedical. Here is the list of Top 10 competitors of Insellar, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Motif neurotech 2022, Houston (United States), Series A	Developer of minimally invasive bioelectronics for mental health disorders	$18.8M	Arboretum Ventures, Dolby Family Ventures ... & 9 others	60/100
2nd	NeuroSigma 2008, Los Angeles (United States), Seed	Develops and commercializes trigeminal nerve stimulation (TNS) devices for treatment of psychiatric disorders	$2.92M	Checkmate Capital, NINDS & 2 others	58/100
3rd	Spark Biomedical 2018, Houston (United States), Series A	Developer of wearable neurostimulation technology for drug-free opioid withdrawal treatment	$31.2M	Wave Ventures, Wellcome Leap & 5 others	57/100
4th	Freespira 2008, Danville (United States), Series D	Medical device & Mobile app to treat panic disorders	$48.9M	Lightspeed Venture Partners, Aphelion Capital ... & 4 others	56/100
5th	Nexalin 2010, Tustin (United States), Public	A non-invasive and drug free treatment for the treatment of anxiety, depression and insomnia	$502K	-	49/100
6th	Cervel 2008, Redwood City (United States), Acquired	Non-invasive neuromodulation through transcranial magnetic stimulation to treat treatment resistant depression	$23.6M	Aberdare Ventures, The D. E. Shaw Group & 1 others	47/100
7th	Sonomind 2025, France, Series A	Developer of a non-invasive therapeutic approach using ultrasound neuromodulation	$25.8M	Bpifrance, Critical Path Ventures	46/100
8th	Neuroelectrics 2011, Barcelona (Spain), Series A	Provider of wireless EEG monitoring and brain stimulation devices	$17.9M	Morningside, Intelectium & 3 others	41/100
9th	Inner Cosmos 2017, Portola Valley (United States), Seed	Provider of AI-based device for treating mood and addiction disorders	$11.9M	Lool Ventures, Starlight Ventures & 5 others	41/100
10th	Rio Grande Neurosciences 2011, San Francisco (United States), Series A	Non-invasive brain stimulation therapies	$8.93M	-	41/100
30th	Insellar 2025, Germany, Seed	Developer of minimally invasive brain interfaces for mental health treatment	$469K	IBB Ventures	20/100